Opendata, web and dolomites

PUPILOSCOPE SIGNED

Pupiloscope, a Neuro-Critical Care Device, Enabling Quantitative, Real-Time, Pupillary Monitoring and Assessment of Patients with Neurotrauma and Head Injuries.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PUPILOSCOPE project word cloud

Explore the words cloud of the PUPILOSCOPE project. It provides you a very rough idea of what is the project "PUPILOSCOPE" about.

potentially    validation    accurate    relatives    brain    an    forecasts    young    engineers    outcomes    disability    error    opinion    hospital    trl    subjective    industry    life    manufacturing    medicating    globally    finalisation    device    clinical    impacting    suffer    markets    skill    quick    secondary    33    solution    breakthrough    light    eyes    monitoring    mild    clinically    pupiloscope    reg    nurses    approval    society    direct    quantitative    million    medical    shining    pupillary    tbi    paramedics    care    alone    worldwide    triage    people    victims    billion    injuries    ce    prototype    leaders    doctors    functional    economics    incorporating    annum    reducing    unmet    seek    human    health    global    positively    threatening    death    healthcare    experts    clinicians    ready    emergency    42    estimate    vivo    traumatic    successfully    critical    approved    head    prone    proven    regulatory    sales    levels    neuro    patient    injury    patients    societal    prevent    launch    time   

Project "PUPILOSCOPE" data sheet

The following table provides information about the project.

Coordinator
VIVO SMART MEDICAL DEVICES LTD 

Organization address
address: 6 EDISON VILLAGE NOTTINGHAM SCIENCE TECHNOLOGY PARK
city: NOTTINGHAM
postcode: NG7 2RF
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.pupiloscope.com
 Total cost 1˙250˙911 €
 EC max contribution 875˙637 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIVO SMART MEDICAL DEVICES LTD UK (NOTTINGHAM) coordinator 875˙637.00

Map

 Project objective

An estimated 42 million people Worldwide suffer a Head Injury (2.5 million in the EU) that can lead to Mild or Traumatic Brain Injury (TBI). It is a major cause of death and disability, especially in young people, impacting victims and relatives, with significant costs to society, estimated at €33 Billion per annum in Europe alone.

Pre-Hospital and Emergency Care Neuro-Monitoring, including pupillary assessment, is critical in the processes of triage, management and medicating patients to prevent secondary injury to the brain. However, the current method of shining a light into a patient's eyes, in order to estimate pupillary response, is subjective and prone to human error.

The solution is Pupiloscope®, enabling Accurate, Real-time, Quantitative Pupillary Monitoring and Assessment for patients with potentially life threatening head injuries. Pupiloscope is a breakthrough technology that will positively impact clinical pathways as well as patient outcomes. It is quick, simple, and easy to use by Doctors, Nurses and Paramedics of all skill levels. Through collaboration with industry experts, key opinion leaders, engineers and Emergency Care based clinicians, who identified the unmet clinical need, ViVO has successfully developed a functional prototype to TRL 6.

As a direct result of this project, Pupiloscope forecasts sales of €20 Million within 5 years of product launch, improving patient outcomes and reducing both the societal and costs of care in the EU and Globally by an estimated €2 Billion per annum.

This project will seek to develop Pupiloscope into a clinically proven, manufacturing ready and CE approved medical device; incorporating technology finalisation, regulatory approval, health economics, clinical testing and validation, therefore enabling product launch and sales to the EU and Global Emergency Care healthcare markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PUPILOSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PUPILOSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More